Pelthos Therapeutics (PTHS) Enterprise Value (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Enterprise Value of -$18.0 million for Q4 2025, down 3413.26% year-over-year from $543966.5 in Q4 2024, and down 26.01% quarter-over-quarter from -$14.3 million in Q3 2025.
Pelthos Therapeutics (PTHS) Enterprise Value (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Enterprise Value history runs 4 years deep, the most recent figure standing at -$18.0 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 3413.26% year-over-year to -$18.0 million; the TTM figure through Dec 2025 stood at -$18.0 million (down 3413.26% YoY), while the FY2025 annual figure was -$18.0 million, down 3413.26% from the prior year.
- Enterprise Value for Q4 2025 stood at -$18.0 million, down from -$14.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$22786.0 in Q3 2023, with the low at -$18.0 million in Q4 2025.
- The 4-year median for Enterprise Value is -$131317.0 (2025), against an average of -$3.1 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value sank 7656.4% in 2024, then soared 97.54% in 2025.
- Pelthos Therapeutics' Enterprise Value stood at -$55074.0 in 2022, then sank by 74.31% to -$96000.0 in 2023, then tumbled by 434.38% to -$513000.0 in 2024, then tumbled by 3413.26% to -$18.0 million in 2025.
- Business Quant data shows PTHS's Enterprise Value at -$18.0 million in Q4 2025, -$14.3 million in Q3 2025, and -$59172.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 2.12 Bn |
| 10 | Pelthos Therapeutics | 91.25 Mn | 66.69 Mn | 21.23 Mn | -24.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.56 Mn |
| Dec 31, 2025 | -18.02 Mn |
| Sep 30, 2025 | -14.30 Mn |
| Jun 30, 2025 | -59,172.00 |
| Mar 31, 2025 | -131,317.00 |
| Dec 31, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -2.41 Mn |
| Mar 31, 2024 | -3.77 Mn |
| Dec 31, 2023 | -96,000.00 |
| Sep 30, 2023 | -22,786.00 |
| Jun 30, 2023 | -81,893.00 |
| Mar 31, 2023 | -48,608.00 |
| Dec 31, 2022 | -55,074.00 |